Skip to main content
. 2018 Jul 8;17:1533033818785496. doi: 10.1177/1533033818785496

Table 5.

Hazards Ratios: Factors Influencing BT and Failure of the Treatment.

Clinical Event Risk Factor HR (95% CI) P Value
Failure Neoadjuvant HT 4.82 (1.25-18.5) .0218
T 1.55 (1.04-2.33) .0326
PSA before CK 1.04 (1.01-1.07) .0474
Biochemical failure Prior TD 0.90 (0.81-0.99) .0275
Months to PSA nadir after the first RT 1.03 (1.02-1.05) .0005

Abbreviations: BT, brachytherapy; CI, confidence interval; CK, CyberKnife; HT, hormone therapy; PSA, prostate-specific antigen; RT, radiotherapy.